We are pleased to announce that Whiz HealthCare Japan 2.0 Investment Limited Partnership made an Investment Agreement on April 6th 2016 with “SymBio Pharmaceuticals Limited” (Located in Minato-ku Tokyo, Fuminori Yoshida President and CEO, JASDAQ: 4582).
Please refer to their press release for further detail.
http://www.symbiopharma.com/news_e/20160406e.pdf (Japanese)